Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing.

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing.

Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14314-9. Unique Identifier : AIDSLINE MED/99045681
Tangri S; Brossay L; Burdin N; Lee DJ; Corr M; Kronenberg M; Division of Developmental Immunology, La Jolla Institute for; Allergy and Immunology, San Diego, CA 92121, USA.

Abstract: Mouse CD1(mCD1) molecules have been reported to present two types of antigens: peptides or proteins and the glycolipid alpha-galactosylceramide. Here, we demonstrate that a protein antigen, chicken ovalbumin (Ova), must be processed to generate peptides presented by mCD1 to CD8(+) T cells. The processing and mCD1-mediated presentation of chicken Ova depend on endosomal localization because inhibitors of endosomal acidification and endosomal recycling pathways block T cell reactivity. Furthermore, a cytoplasmic tail mutant of mCD1, which disrupts endosomal localization, has a greatly reduced capacity to present Ova to mCD1 restricted cells. Newly synthesized mCD1 molecules, however, are not required for Ova presentation, suggesting that molecules recycling from the cell surface are needed. Because of these data showing that mCD1 trafficks to endosomes, where it can bind peptides derived from exogenous proteins, we conclude that peptide antigen presentation by mCD1 is likely to be a naturally occurring phenomenon. In competition assays, alpha-galactosylceramide did not inhibit Ova presentation, and presentation of the glycolipid was not inhibited by excess Ova or the peptide epitope derived from it. This suggests that, although both lipid and peptide presentation may occur naturally, mCD1 may interact differently with these two types of antigens.

Keywords: JOURNAL ARTICLE Amino Acid Sequence Animal Antibody Formation Antigen-Presenting Cells/*IMMUNOLOGY Antigens/IMMUNOLOGY Antigens, CD1/*PHYSIOLOGY ABC Transporters/GENETICS/PHYSIOLOGY Chickens Crosses, Genetic CD8-Positive T-Lymphocytes/IMMUNOLOGY Endosomes/*IMMUNOLOGY Epitopes/CHEMISTRY/IMMUNOLOGY Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Knockout Molecular Sequence Data Ovalbumin/IMMUNOLOGY Peptide Fragments/CHEMISTRY/IMMUNOLOGY Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S.
990330
A9931032

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .